NCT03564405View on ClinicalTrials.gov

Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular Carcinoma

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 5, 2016

Primary Completion Date

March 7, 2017

Study Completion Date

May 17, 2017

Conditions
Hepatocellular Carcinoma Non-resectable
Interventions
DEVICE

UNI-DEB

Applicate the TACE with UNI-DEB to unresectable hepatocellular carcinoma patient

Trial Locations (1)

Unknown

Catholic University Seoul St. Mary Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Jeil Pharmaceutical Co., Ltd.

INDUSTRY

NCT03564405 - Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter